|
The University of Minnesota Medical School
neurotransmitter testing paper. |
|
|
The
first distinction between laboratories performing
neurotransmitter testing is:
Under
these two headings the differences laboratories are discussed.
Medical
doctors are taught to place a high degree of
trust in the hospital and clinic labs.
At the heart of this trust are those
directing the medical laboratory who are in
charge of quality control. NeuroResearch Clinics has found that there
are non-hospital, non-clinic labs out there
that may not deserve this trust this same
trust as labs directed by hospital based
board certified laboratory medicine
pathologists.
In contracting early
on with labs not run by medical doctors,
after several thousand labs were obtained it
was realized that urinary neurotransmitter testing results being reported were not calibrated to
hospital standards. In turn this caused
NeuroResearch Clinics to discard (throw out)
thousands of serotonin and dopamine urinary
neurotransmitter testing reports. This type of
serotonin and dopamine urinary
neurotransmitter testing is still available
to this day. We get regular reports from
physicians using the baseline urinary
neurotransmitter testing approach prior to
treatment recommended by these laboratories claiming that
virtually none of their patients achieved
relief of symptoms. This raises the
question, "Why are these doctors continuing
to use the baseline urinary neurotransmitter testing approach prior to treatment if it
does not achieve relief of symptoms in
most patients and the peer reviewed medical
literature specifically notes that it is of
no value?
Best rule of thumb in ordering neurotransmitter testing is to make sure a hospital based MD
pathologist who is board certified
laboratory medicine is directing the laboratory
quality control in the
lab samples
are being sent to and run in. |
|
|
|
The MD Versus
non-MD Laboratory
|
|
Area of Concern |
|
non-MD Laboratories |
Comments |
|
|
Laboratory directed by: |
Board certified hospital
based laboratory pathologist (MD) |
No MD in charge
(chemist) |
- - - |
|
Laboratory director has hospital
staff privileges |
Yes |
No |
- - - |
|
Laboratory director has formal
training in treating patients. |
Yes |
No |
- - - |
|
Laboratory director has a license
to practice medicine |
Yes |
No |
- - - |
|
Laboratory director has hospital or
clinic patient care responsibilities |
Yes |
No |
- - - |
|
Laboratory director able to make
patient care recommendations under medical license. |
Yes |
No |
- - - |
|
Recommends baseline
neurotransmitter testing prior to treatment |
No |
Yes |
Baseline testing prior
to treatment is of
no value if the goal of treatment is relief of
symptoms. |
|
Claims that monoamine
neurotransmitters cross the blood brain barrier |
No |
Yes |
The scientific
literature is clear the monoamine neurotransmitters
do not cross the blood brain barrier. |
|
Claims that
neurotransmitters are simply filtered by the kidney
and excreted in the urine |
No |
Yes |
The scientific
literature is clear the monoamine neurotransmitters
in the urine are synthesized by the kidneys. |
|
Reports that almost all
urinary neurotransmitter levels performed prior to
starting treatment are low or in the low end of the
reference range |
No |
Yes |
The should be a uniform
distribution of baseline test results with 95% of
test results falling evenly across the reported
reference range. |
|
Identifies which of the
three phases of neurotransmitter response the sample
is in for patients taking nutrients. |
Yes |
No |
As noted in the
University of Minnesota Medical School paper there
are three phases of response when administering
nutrients. |
|
Laboratory director has license to make drug dosing
recommendation changes based on lab testing. |
Yes |
No |
Only doctors with a
medical license and DEA license are qualified to
make dosing change recommendation with prescription
drugs. |
|
Best rule of thumb in ordering neurotransmitter testing is to make sure a hospital based MD
pathologist who is board certified laboratory
medicine is directing the laboratory the lab samples
are being sent to and run in.
neurotransmitter testing-QUALITY
CONTROL |
